Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy

Conclusion: New radiotracer-avid lesions on 18F-DCFPyL PET/CT in men with mCRPC undergoing BAT can indicate early progression.

Source: Journal of Nuclear Medicine - September 2, 2021 Category: Nuclear Medicine Authors: Markowski, M. C., Velho, P. I., Eisenberger, M. A., Pomper, M. G., Pienta, K. J., Gorin, M. A., Antonarakis, E. S., Denmeade, S. R., Rowe, S. P. Tags: Clinical Source Type: research